Tissue- vs iPSC-derived tumor organoids for cancer research
Organoid models for cancer research can largely be differentiated into two types: tissue-derived organoids and iPSC-derived organoids. In this infographic, part of our In Focus on organoids for cancer research, supported by Sartorius, we detail the differences in their preparation, the pros and cons of each type and provide key tips for their development and implementation. DOWNLOAD NOW This content was provided by Follow Sartorius on Twitter, Facebook and on LinkedIn.
To view this content, please register now for access
Join our member community for FREE to access a collection of journal and online-only features, including:
- Exclusive access to educational videos, eBooks and insights into top BioTechniques journal articles
- The latest news and journal updates delivered straight to your inbox when you want it
- Personalized recommendations for the latest member-exclusive podcasts, interviews and expert opinions
- Priority registration to webinars, panel discussions and events
- Access to competitions and journal publication discounts, including 10% off open access fees when you sign up today!
